Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...

Avery Dennison’s second quarter results largely reflected the effects of shifting trade policy and segment-specific demand fluctuations, as the company navigated a complex economic backdrop. While ...

Adhesive manufacturing company Avery Dennison (NYSE:AVY) fell short of the market’s revenue expectations in Q2 CY2025, with ...